On November 16, 2026, the U.S. Environmental Protection Agency published a notice of data availability in the Federal Register, 91 FR 73579 (FR Doc. 2026-23263), on the draft risk evaluation of HHCB under the Toxic Substances Control Act. US manufacturers and importers of HHCB (galaxolide, CAS 1222-05-5), US fragrance compounders that formulate HHCB into fragrance mixtures, US producers of detergents, cleaners and air fresheners that use HHCB under TSCA conditions of use, and US processors and distributors of HHCB and HHCB-containing household products must review the 24 industry studies that are public in HERO, listed in the HHCB Data Availability Memorandum in docket EPA-HQ-OPPT-2018-0430, and file comments on those studies in the context of the draft HHCB risk evaluation by December 16, 2026, or comments received after December 16, 2026 are not considered and EPA will finalize the HHCB risk evaluation, and a finding of unreasonable risk would require TSCA section 6(a) restrictions on manufacture (including import), processing, distribution, use or disposal.

The notice does not reopen the April 14, 2026 to June 15, 2026 comment period on the draft risk evaluation. It asks only for comment on 24 industry-submitted studies that an administrative error in EPA's Health and Environmental Research Online (HERO) system kept off the public record during that window, and that EPA restored in HERO on October 14, 2026. The list is the HHCB Data Availability Memorandum in docket EPA-HQ-OPPT-2018-0430. Comments must be received on or before December 16, 2026.

What does 91 FR 73579 add to the HHCB draft?

HHCB (CASRN 1222-05-5) is a synthetic musk compound found widely in fragrances and used in household products such as detergents, cleaners and air fresheners. The notice treats those household uses as TSCA conditions of use, and it calls perfumes, cosmetics and personal care products non-TSCA uses of the same substance.

EPA designated HHCB a high-priority substance in December 2019, took comment on a draft scope (85 FR 19941, April 9, 2020) and issued the final scope (85 FR 55281, September 4, 2020). In April 2026 it released the draft risk evaluation for public comment and for peer review by the Science Advisory Committee on Chemicals. During the April 14, 2026 to June 15, 2026 window, 24 industry studies already used in the Draft Human Health and Environmental Hazard Assessment were not readable in HERO. 91 FR 73579 opens comment on those studies only.

StepDate
High-priority designationDecember 2019
Draft scope, 85 FR 19941April 9, 2020
Final scope, 85 FR 55281September 4, 2020
Draft risk evaluation commentsApril 14, 2026 to June 15, 2026
24 studies restored in HEROOctober 14, 2026
91 FR 73579 publishedNovember 16, 2026
Comments dueDecember 16, 2026

Who has to file on the 24 studies?

The notice is directed to persons who manufacture (TSCA section 3(9) includes import), process, distribute, use or dispose of HHCB, and to trade groups, NGOs, State and local governments and Tribal Nations. The companies that must act are those whose TSCA conditions of use include HHCB in fragrance mixtures, detergents, cleaners and air fresheners.

The notice ties exposure to dust, mist or vapor for workers and for consumers during cleaning, air-freshener use or laundry, and to down-the-drain releases into publicly owned treatment works. A comment that repeats the closed April to June docket, without the 24 studies, does not answer the question EPA posed. Obsidian tracks 7 regulatory texts (in force, amended or in preparation) under TSCA in the United States, as of November 2026.

What should the December 16, 2026 comment contain?

File in docket EPA-HQ-OPPT-2018-0430. EPA wants feedback on the 24 studies in the context of the draft, specifically the studies considered in the draft human health and environmental hazard assessment. Open each study in HERO and say whether it changes a hazard conclusion, an exposure assumption or a weight-of-evidence call.

  • Tie each point to a study named in the HHCB Data Availability Memorandum.
  • Name the condition of use: manufacture or import, compounding, a detergent, cleaner or air freshener, or disposal to a treatment works.
  • Do not send confidential business information through Regulations.gov or email. Mark CBI under EPA's docket instructions. Disclosure follows 40 CFR parts 2 and 703.
  • Submit so the comment is received on or before December 16, 2026.

What follows an unreasonable-risk finding?

EPA will consider comments on this notice while it finalizes the HHCB risk evaluation. The notice sets no date for that document. Under TSCA section 6 (15 U.S.C. 2605), the final evaluation decides, on the weight of scientific evidence and without costs, whether HHCB presents an unreasonable risk under its conditions of use. A positive finding must go to section 6(a) risk management: a rule restricting manufacture (including import), processing, distribution, use or disposal, with its own later comment period. See EPA's page on assessing and managing chemicals under TSCA. A filing received after December 16, 2026 is not considered.

Per-jurisdiction monitoring of Federal Register chemical notices is what puts a short data-availability window in front of the teams that still have a filing to make.

Live
EPA TSCA Section 6 risk evaluation framework and risk management rules
Monitor US EPA Toxic Substances Control Act Section 6 rulemaking for the chemicals and advanced materials industry.
Email 300+ news

Before December 16, 2026, separate TSCA conditions of use from the non-TSCA perfume, cosmetic and personal-care uses the notice sets aside, file a study-specific comment from the memorandum and HERO in EPA-HQ-OPPT-2018-0430, and brief product stewardship that a late comment will not be read.